220 related articles for article (PubMed ID: 2109100)
1. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.
Ashorn PA; Berger EA; Moss B
J Virol; 1990 May; 64(5):2149-56. PubMed ID: 2109100
[TBL] [Abstract][Full Text] [Related]
2. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
Broder CC; Dimitrov DS; Blumenthal R; Berger EA
Virology; 1993 Mar; 193(1):483-91. PubMed ID: 8438583
[TBL] [Abstract][Full Text] [Related]
3. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
Broder CC; Berger EA
J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
5. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
Nussbaum O; Broder CC; Berger EA
J Virol; 1994 Sep; 68(9):5411-22. PubMed ID: 8057423
[TBL] [Abstract][Full Text] [Related]
6. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
LaBonte JA; Madani N; Sodroski J
J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
[TBL] [Abstract][Full Text] [Related]
7. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
8. The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation.
Mulligan MJ; Kumar P; Hui HX; Owens RJ; Ritter GD; Hahn BH; Compans RW
AIDS Res Hum Retroviruses; 1990 Jun; 6(6):707-20. PubMed ID: 2364016
[TBL] [Abstract][Full Text] [Related]
9. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
[TBL] [Abstract][Full Text] [Related]
10. Syncytium-inducing capacity of human immunodeficiency virus (HIV): analysis by the use of cloned viruses.
el-Farrash MA; Harada S
Microbiol Immunol; 1989; 33(7):549-59. PubMed ID: 2505024
[TBL] [Abstract][Full Text] [Related]
11. Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction.
Dimitrov DS; Broder CC; Berger EA; Blumenthal R
J Virol; 1993 Mar; 67(3):1647-52. PubMed ID: 8437234
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
Vincent MJ; Raja NU; Jabbar MA
J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
[TBL] [Abstract][Full Text] [Related]
13. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.
LaBonte JA; Patel T; Hofmann W; Sodroski J
J Virol; 2000 Nov; 74(22):10690-8. PubMed ID: 11044113
[TBL] [Abstract][Full Text] [Related]
14. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.
Dragic T; Charneau P; Clavel F; Alizon M
J Virol; 1992 Aug; 66(8):4794-802. PubMed ID: 1629956
[TBL] [Abstract][Full Text] [Related]
15. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1.
Frey S; Marsh M; Günther S; Pelchen-Matthews A; Stephens P; Ortlepp S; Stegmann T
J Virol; 1995 Mar; 69(3):1462-72. PubMed ID: 7853478
[TBL] [Abstract][Full Text] [Related]
16. A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
Elson HF; Dimitrov DS; Blumenthal R
Mol Membr Biol; 1994; 11(3):165-9. PubMed ID: 7742881
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
Ashorn P; Berger EA; Moss B
Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
[No Abstract] [Full Text] [Related]
18. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
Berman PW; Nakamura GR
AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
[TBL] [Abstract][Full Text] [Related]
20. Interactions of CD4+ plasma membrane vesicles with HIV-1 and HIV-1 envelope glycoprotein-expressing cells.
Puri A; Dimitrov DS; Golding H; Blumenthal R
J Acquir Immune Defic Syndr (1988); 1992; 5(9):915-20. PubMed ID: 1512692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
